Cargando…

Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir

BACKGROUND: Disseminated intravascular coagulation (DIC) is a very rare complication of disseminated cytomegalovirus (CMV) infection. So far it is mainly described for immunocompromised patients. CASE PRESENTATION: A 49-year-old immunocompetent Caucasian male presented with sudden onset of fever and...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Niklas F., Schampera, Matthias, Jahn, Gerhard, Malek, Nisar P., Berg, Christoph P., Hamprecht, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719720/
https://www.ncbi.nlm.nih.gov/pubmed/26787617
http://dx.doi.org/10.1186/s12879-016-1343-3
_version_ 1782410966006235136
author Müller, Niklas F.
Schampera, Matthias
Jahn, Gerhard
Malek, Nisar P.
Berg, Christoph P.
Hamprecht, Klaus
author_facet Müller, Niklas F.
Schampera, Matthias
Jahn, Gerhard
Malek, Nisar P.
Berg, Christoph P.
Hamprecht, Klaus
author_sort Müller, Niklas F.
collection PubMed
description BACKGROUND: Disseminated intravascular coagulation (DIC) is a very rare complication of disseminated cytomegalovirus (CMV) infection. So far it is mainly described for immunocompromised patients. CASE PRESENTATION: A 49-year-old immunocompetent Caucasian male presented with sudden onset of fever and DIC due to primary CMV infection, which was treated with Valganciclovir. CMV-specific IgG-avidity and epithelial cell-specific neutralisation-capacity developed five weeks after onset of symptoms. We describe the first case of an immunocompetent patient suffering from DIC due to a CMV primary infection successfully treated with Valganciclovir. CONCLUSIONS: Primary CMV infection can occur accompanied with life threatening complications even in immunocompetent patients. Immediate treatment with Valganciclovir should be considered as an early treatment of choice in severe cases since specific neutralisation capacity might need several weeks to develop. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1343-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4719720
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47197202016-01-21 Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir Müller, Niklas F. Schampera, Matthias Jahn, Gerhard Malek, Nisar P. Berg, Christoph P. Hamprecht, Klaus BMC Infect Dis Case Report BACKGROUND: Disseminated intravascular coagulation (DIC) is a very rare complication of disseminated cytomegalovirus (CMV) infection. So far it is mainly described for immunocompromised patients. CASE PRESENTATION: A 49-year-old immunocompetent Caucasian male presented with sudden onset of fever and DIC due to primary CMV infection, which was treated with Valganciclovir. CMV-specific IgG-avidity and epithelial cell-specific neutralisation-capacity developed five weeks after onset of symptoms. We describe the first case of an immunocompetent patient suffering from DIC due to a CMV primary infection successfully treated with Valganciclovir. CONCLUSIONS: Primary CMV infection can occur accompanied with life threatening complications even in immunocompetent patients. Immediate treatment with Valganciclovir should be considered as an early treatment of choice in severe cases since specific neutralisation capacity might need several weeks to develop. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1343-3) contains supplementary material, which is available to authorized users. BioMed Central 2016-01-19 /pmc/articles/PMC4719720/ /pubmed/26787617 http://dx.doi.org/10.1186/s12879-016-1343-3 Text en © Müller et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Müller, Niklas F.
Schampera, Matthias
Jahn, Gerhard
Malek, Nisar P.
Berg, Christoph P.
Hamprecht, Klaus
Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir
title Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir
title_full Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir
title_fullStr Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir
title_full_unstemmed Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir
title_short Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir
title_sort case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719720/
https://www.ncbi.nlm.nih.gov/pubmed/26787617
http://dx.doi.org/10.1186/s12879-016-1343-3
work_keys_str_mv AT mullerniklasf casereportseverecytomegalovirusprimaryinfectioninanimmunocompetentadultwithdisseminatedintravascularcoagulationtreatedwithvalganciclovir
AT schamperamatthias casereportseverecytomegalovirusprimaryinfectioninanimmunocompetentadultwithdisseminatedintravascularcoagulationtreatedwithvalganciclovir
AT jahngerhard casereportseverecytomegalovirusprimaryinfectioninanimmunocompetentadultwithdisseminatedintravascularcoagulationtreatedwithvalganciclovir
AT maleknisarp casereportseverecytomegalovirusprimaryinfectioninanimmunocompetentadultwithdisseminatedintravascularcoagulationtreatedwithvalganciclovir
AT bergchristophp casereportseverecytomegalovirusprimaryinfectioninanimmunocompetentadultwithdisseminatedintravascularcoagulationtreatedwithvalganciclovir
AT hamprechtklaus casereportseverecytomegalovirusprimaryinfectioninanimmunocompetentadultwithdisseminatedintravascularcoagulationtreatedwithvalganciclovir